Near-infrared laparoscopic fluorescence for pelvic side wall delta mapping in patients with rectal cancer--'PINPOINT' nodal assessment.
M KazanowskiH Al FurajiiRonan A CahillPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2016)
Low rectal cancers metastase lymphatically to the pelvic side wall in addition to cephalad spread alongside the superior rectal/inferior mesenteric arterial axis. Radical surgery in the West has focused resectional intent and effort on the midline en bloc oncological package by Total Mesorectal Excision. While neoadjuvant chemo/radiotherapy (now often administered to patients with radiologically locally advanced cancer) may contribute significant therapeutic effect to the lateral pelvic side walls, many patients with earlier preoperative stage low rectal cancer are offered surgery first (and indeed solely). Furthermore, some of those pretreated may have residual in situ lateral nodal disease and so risk understaging and undertreatment. Routine extended lymphadenectomy is on the other hand unproven with respect to survival benefit and has likely no added role in the absence of definite (rather than possible) side-wall involvement. Near-infrared fluorescence pelvic side-wall delta mapping, as illustrated here in five patients undergoing abdominoperineal resection for rectal cancer after neoadjuvant therapy, may give the technological capacity to identify tumor site-draining nodes on the pelvic side and the focus the operating surgeon on this potential target for surgical resection (whether by berry picking or nerve sparing clearance) and prompt individualized diagnostic and therapeutic selection.
Keyphrases
- rectal cancer
- locally advanced
- neoadjuvant chemotherapy
- minimally invasive
- robot assisted
- patients undergoing
- lymph node
- advanced cancer
- sentinel lymph node
- palliative care
- coronary artery bypass
- high resolution
- early stage
- single molecule
- radiation therapy
- squamous cell carcinoma
- mesenchymal stem cells
- risk assessment
- prostate cancer
- drug delivery
- surgical site infection
- radiation induced
- clinical practice
- free survival
- atrial fibrillation
- cancer therapy
- radical prostatectomy